Skip to main content

Change location

You are currently on the Global (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Global (English)
  • Careers
  • Media and News
  • Get in touch
    • Global (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
    • X-ray/CT
    • MRI
    • CEUS
    • Molecular Imaging
    • Cardiovascular
    • Digital Health
    • Oncology
    • Cardiology
    • Innovation
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
      • Cell Therapy
      • Research Products
        • BubbleGen CD3+ Cell Selection Kit
        • BubbleGen Cell Separators
      • Resources
    • Education
    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
    • Events
    • Key International conferences
    • Global Educational events
    • Sustainability Overview
    • Decarbonization and Environment
    • Innovation and Education
    • Empowering People
    • Trust and Governance
  • Our Stories
232 results found
Page
Dosage Calculator Gadopiclenol: Patient-specific dosing recommendations
Bracco Vueway Gadopiclenol
Article
Bracco Imaging earns its first EcoVadis Platinum Medal: in Global Top 1% Bracco Imaging has been awarded the EcoVadis Platinum Medal, placing the company among the top 1% of over 100,000 organizations assessed globally for their sustainability performance.
Bracco Imaging Ecovadis 2025
Article
Bracco Group takes centre stage at health and well-being week at Expo Osaka Bracco Group is one of the leading participants at Expo Osaka. As a Gold Sponsor of the Italy Pavilion, Bracco, global leader in diagnostic imaging, is actively engaged in several key events during Health and Well-Being Week from 20 June 20 to 1 July.
2025 Expo Osaka, Bracco Japan - Ito Mancho
Article
Re.Water Project – Bracco Sustainability The Re.Water Project tackles the environmental impact of contrast agents through an innovative urine collection and filtration system. Developed with Zero, the pilot will launch in 2025 across selected European hospitals.
Re.Water Project – Bracco Sustainability
Article
Empowering Next Generation Leaders in Radiology The Bracco NextGen Radiology Initiative supports a more sustainable and equitable healthcare future by empowering the radiologists of tomorrow.
Empowering Next Generation Leaders in Radiology
Article
Bracco Imaging Receives Regulatory Approval in China for Sulphur hexafluoride (SF6) in the Assessment of Fallopian Tube Patency New indication of SF6 microbubbles supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China.
ultrasound pr
Article
Clinical impact of Gadopiclenol in Breast MRI We are pleased to invite you to join an educational webinar entitled Clinical impact of Gadopiclenol in Breast MRI scheduled for October 21 from 6:00 to 7:00 pm CET.
Bracco Vueway
Article
AiMIFY enhancing medical imaging with AI AiMIFY is Bracco Imaging’s new AI software that revolutionizes contrast-enhanced brain MRI, improving image quality and supporting more confident and sustainable diagnoses.
AiMIFY enhancing medical imaging with AI
Article
AI-powered Contrast Enhancement for Brain MRI With AiMIFY™ FDA clearance in 2024 and subsequent CE Mark in 2025, Bracco has taken another step forward in its shared mission of providing innovative artificial intelligence (AI)-based solutions that can improve diagnostic confidence and support radiologists and patients worldwide.
EUSOMII AI-powered Contrast Enhancement for Brain MRI
Page
Scientific Information Inquiry Fill in this form to receive information about medical and clinical aspects of a product.
No image available
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Education
  • Events
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182